Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
138.15B | 152.41B | 125.93B | 110.05B | 95.31B | 81.59B | Gross Profit |
72.88B | 84.66B | 73.82B | 63.01B | 52.74B | 40.95B | EBIT |
45.92B | 57.08B | 50.81B | 42.91B | 34.60B | 22.83B | EBITDA |
50.32B | 63.56B | 54.25B | 46.30B | 37.39B | 25.62B | Net Income Common Stockholders |
35.19B | 43.37B | 36.74B | 32.55B | 24.92B | 15.95B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
41.38B | 125.19B | 102.12B | 107.26B | 71.24B | 65.66B | Total Assets |
112.81B | 243.48B | 217.37B | 187.37B | 163.71B | 143.47B | Total Debt |
8.89B | 12.16B | 11.75B | 6.10B | 6.83B | 7.93B | Net Debt |
-32.49B | -113.03B | -90.36B | -101.17B | -64.41B | -57.73B | Total Liabilities |
27.40B | 48.40B | 56.24B | 40.89B | 42.92B | 43.73B | Stockholders Equity |
85.42B | 195.08B | 161.13B | 146.47B | 120.80B | 99.73B |
Cash Flow | Free Cash Flow | ||||
29.17B | 31.79B | 14.37B | 42.88B | 11.50B | 19.94B | Operating Cash Flow |
33.35B | 36.92B | 21.79B | 46.95B | 14.63B | 22.28B | Investing Cash Flow |
-4.93B | -5.96B | -7.68B | -7.43B | -4.23B | -8.44B | Financing Cash Flow |
-16.65B | -15.97B | -22.48B | -9.98B | -6.96B | -6.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $10.34B | 48.89 | 16.14% | 0.70% | -18.33% | -11.92% | |
76 Outperform | $78.54B | 38.00 | 12.13% | 1.02% | -32.32% | -40.19% | |
74 Outperform | $37.96B | 37.07 | 14.04% | 0.52% | -2.99% | -0.46% | |
62 Neutral | $37.09B | ― | -51.45% | ― | 1.00% | -148.89% | |
59 Neutral | $27.83B | 1.88 | -18.16% | 4.00% | 2.13% | -44.45% | |
49 Neutral | $1.54B | ― | -3.41% | ― | 13.26% | 83.01% |